Detalhe da pesquisa
1.
Development and validation of a clinical decision support system based on PSA, microRNAs, and MRI for the detection of prostate cancer.
Eur Radiol
; 2024 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38177618
2.
68Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC): a prospective single-centre study in patients eligible for salvage therapy.
Eur J Nucl Med Mol Imaging
; 47(12): 2804-2815, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32314028
3.
Circulating microRNAs combined with PSA for accurate and non-invasive prostate cancer detection.
Carcinogenesis
; 40(2): 246-253, 2019 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-30452625
4.
New insights on occupational exposure and bladder cancer risk: a pooled analysis of two Italian case-control studies.
Int Arch Occup Environ Health
; 92(3): 347-359, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30506367
5.
Prostate Cancer Detection Rate with Koelis Fusion Biopsies versus Cognitive Biopsies: A Comparative Study.
Urol Int
; 97(2): 230-7, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27256369
6.
A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
Prostate
; 75(11): 1177-86, 2015 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25893930
7.
DKK-1 in prostate cancer diagnosis and follow up.
BMC Clin Pathol
; 14(1): 11, 2014 Mar 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-24655661
8.
Prognostic factors of 'high-grade' Ta bladder cancers according to the WHO 2004 classification: are these equivalent to 'high-risk' non-muscle-invasive bladder cancer?
Urol Int
; 92(2): 136-42, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24080613
9.
Polymorphisms in the XRCC1 gene modify survival of bladder cancer patients treated with chemotherapy.
Int J Cancer
; 133(8): 2004-9, 2013 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23553206
10.
Prognostic factors including Ki-67 and p53 in Bacillus Calmette-Guérin-treated non-muscle-invasive bladder cancer: a prospective study.
Urol Int
; 90(2): 184-90, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23328160
11.
Patient and Context Factors in the Adoption of Active Surveillance for Low-Risk Prostate Cancer.
JAMA Netw Open
; 6(10): e2338039, 2023 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37847502
12.
Ki-67, topoisomerase IIα and miR-221 have a limited prostate cancer risk stratification ability on a medium-term follow-up: results of a high-risk radical prostatectomy cohort.
Transl Androl Urol
; 11(9): 1271-1281, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36217395
13.
Association Study between Polymorphisms in DNA Methylation-Related Genes and Testicular Germ Cell Tumor Risk.
Cancer Epidemiol Biomarkers Prev
; 31(9): 1769-1779, 2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35700037
14.
Adrenal ganglioneuroma with multifocal retroperitoneal extension: a challenging diagnosis.
ScientificWorldJournal
; 11: 1548-53, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22224068
15.
Low Levels of Urinary PSA Better Identify Prostate Cancer Patients.
Cancers (Basel)
; 13(14)2021 Jul 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34298784
16.
Two Novel Ceramide-Like Molecules and miR-5100 Levels as Biomarkers Improve Prediction of Prostate Cancer in Gray-Zone PSA.
Front Oncol
; 11: 769158, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34868998
17.
Effect of finasteride on the sensitivity of PSA to detect prostate cancer in rebiopsy series.
Arch Ital Urol Androl
; 82(4): 135-8, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21341547
18.
Transperineal Free-hand mpMRI Fusion-targeted Biopsies Under Local Anesthesia: Technique and Feasibility From a Single-center Prospective Study.
Urology
; 140: 122-131, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32061825
19.
Fatal haematuria in a patient with an orthotopic neobladder and chronic liver failure.
Urol Int
; 83(3): 368-9, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19829044
20.
Comparison between two commercially available chromogranin A assays in detecting neuroendocrine differentiation in prostate cancer and benign prostate hyperplasia.
Clin Chim Acta
; 377(1-2): 103-7, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17034778